Comments
Loading...

Amgen Analyst Ratings

AMGNNASDAQ
Logo brought to you by Benzinga Data
$287.01
At close: Jun 4 EDT
$287.44
0.430.15%
Pre-Market: 6:37 PM EDT
Consensus Rating1
Neutral
Highest Price Target1
$405.00
Lowest Price Target1
$200.00
Consensus Price Target1
$315.30

Amgen Analyst Ratings and Price Targets | NASDAQ:AMGN | Benzinga

Amgen Inc has a consensus price target of $315.3 based on the ratings of 33 analysts. The high is $405 issued by Cantor Fitzgerald on October 22, 2024. The low is $200 issued by Credit Suisse on July 12, 2023. The 3 most-recent analyst ratings were released by Guggenheim, Piper Sandler, and Mizuho on May 20, 2025, May 16, 2025, and May 7, 2025, respectively. With an average price target of $298.67 between Guggenheim, Piper Sandler, and Mizuho, there's an implied 3.91% upside for Amgen Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
1
1
Feb
1
Mar
2
Apr
2
3
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Guggenheim
Piper Sandler
Mizuho
UBS
RBC Capital

1calculated from analyst ratings

Analyst Ratings for Amgen

Buy NowGet Alert
05/20/2025Buy Now0.19%Guggenheim
Vamil Divan73%
→ $288Assumes → NeutralGet Alert
05/16/2025Buy Now14.11%Piper Sandler
David Amsellem73%
$329 → $328MaintainsOverweightGet Alert
05/07/2025Buy Now-2.59%Mizuho
Salim Syed44%
$235 → $280MaintainsNeutralGet Alert
05/02/2025Buy Now9.59%UBS
Trung Huynh67%
$319 → $315MaintainsNeutralGet Alert
05/02/2025Buy Now11.33%RBC Capital
Gregory Renza50%
$324 → $320MaintainsOutperformGet Alert
04/14/2025Buy Now10.98%UBS
Colin Bristow38%
$315 → $319MaintainsNeutralGet Alert
04/09/2025Buy Now14.81%Morgan Stanley
Terence Flynn65%
$328 → $330MaintainsEqual-WeightGet Alert
03/05/2025Buy Now2.28%B of A Securities
Tim Anderson62%
$275 → $294MaintainsUnderperformGet Alert
02/10/2025Buy Now14.46%Piper Sandler
David Amsellem73%
$310 → $329MaintainsOverweightGet Alert
02/06/2025Buy Now-4.33%B of A Securities
Tim Anderson62%
$256 → $275MaintainsUnderperformGet Alert
02/05/2025Buy Now14.11%Morgan Stanley
Terence Flynn65%
$322 → $328MaintainsEqual-WeightGet Alert
01/29/2025Buy Now20.37%BMO Capital
Evan David Seigerman46%
$362 → $346MaintainsOutperformGet Alert
01/28/2025Buy Now2.63%Citigroup
Geoff Meacham62%
$310 → $295MaintainsNeutralGet Alert
01/24/2025Buy Now12.72%RBC Capital
Gregory Renza50%
$324 → $324ReiteratesOutperform → OutperformGet Alert
01/10/2025Buy Now-2.59%Wells Fargo
Mohit Bansal66%
$335 → $280MaintainsEqual-WeightGet Alert
01/08/2025Buy Now3.67%Truist Securities
Robyn Karnauskas54%
$333 → $298MaintainsHoldGet Alert
01/02/2025Buy Now7.85%Piper Sandler
David Amsellem73%
$344 → $310MaintainsOverweightGet Alert
12/10/2024Buy Now-10.94%B of A Securities
Tim Anderson62%
→ $256Reinstates → UnderperformGet Alert
11/27/2024Buy Now14.81%RBC Capital
Gregory Renza50%
$360 → $330MaintainsOutperformGet Alert
11/15/2024Buy NowWolfe Research
Tim Anderson62%
Initiates → Peer PerformGet Alert
11/14/2024Buy Now16.55%Citigroup
Geoff Meacham62%
→ $335Initiates → NeutralGet Alert
11/12/2024Buy Now32.2%Jefferies
Michael Yee56%
$380 → $380MaintainsBuyGet Alert
10/31/2024Buy Now13.41%UBS
Colin Bristow38%
$335 → $326MaintainsNeutralGet Alert
10/22/2024Buy Now40.9%Cantor Fitzgerald
Olivia Brayer53%
$405 → $405ReiteratesOverweight → OverweightGet Alert
10/21/2024Buy Now33.25%TD Cowen
Yaron Weber37%
$381 → $383MaintainsBuyGet Alert
10/17/2024Buy Now32.2%Bernstein
Aaron Gal54%
→ $380Initiates → OutperformGet Alert
10/14/2024Buy Now15.85%Truist Securities
Robyn Karnauskas54%
$320 → $333DowngradeBuy → HoldGet Alert
10/07/2024Buy Now9.59%Barclays
Carter Gould55%
$300 → $315MaintainsEqual-WeightGet Alert
09/27/2024Buy Now40.9%Cantor Fitzgerald
Olivia Brayer53%
→ $405Initiates → OverweightGet Alert
09/26/2024Buy Now25.94%RBC Capital
Gregory Renza50%
$362 → $362ReiteratesOutperform → OutperformGet Alert
09/25/2024Buy Now-25.2%Baird
Brian Skorney57%
$215 → $215ReiteratesUnderperform → UnderperformGet Alert
08/07/2024Buy Now32.55%TD Cowen
Yaron Weber37%
$360 → $381MaintainsBuyGet Alert
08/07/2024Buy Now32.2%Oppenheimer
Jay Olson60%
$380 → $380MaintainsOutperformGet Alert
08/07/2024Buy Now6.11%Deutsche Bank
James Shin45%
$310 → $305ReiteratesHold → HoldGet Alert
08/07/2024Buy Now14.81%B of A Securities
Geoff Meacham62%
$325 → $330MaintainsNeutralGet Alert
08/07/2024Buy Now25.94%RBC Capital
Gregory Renza50%
$332 → $362MaintainsOutperformGet Alert
08/07/2024Buy Now16.55%Wells Fargo
Mohit Bansal66%
$320 → $335DowngradeOverweight → Equal-WeightGet Alert
07/12/2024Buy Now17.24%UBS
Colin Bristow38%
$307 → $337MaintainsNeutralGet Alert
07/11/2024Buy Now5.41%Morgan Stanley
Terence Flynn65%
$310 → $303MaintainsEqual-WeightGet Alert
06/27/2024Buy Now18.29%Argus Research
David Toung69%
$300 → $340MaintainsBuyGet Alert
06/14/2024Buy Now15.5%RBC Capital
Gregory Renza50%
$328 → $332MaintainsOutperformGet Alert
05/09/2024Buy Now-18.24%Mizuho
Salim Syed44%
$223 → $235MaintainsNeutralGet Alert
05/03/2024Buy Now14.11%RBC Capital
Gregory Renza50%
$332 → $328MaintainsOutperformGet Alert
05/03/2024Buy Now7.85%Morgan Stanley
Terence Flynn65%
$271 → $310MaintainsEqual-WeightGet Alert
05/03/2024Buy Now6.8%UBS
Colin Bristow38%
$284 → $307MaintainsNeutralGet Alert
05/03/2024Buy NowWilliam Blair
Matthew Phipps11%
UpgradeMarket Perform → OutperformGet Alert
05/03/2024Buy Now23.5%BMO Capital
Evan David Seigerman46%
$336 → $355MaintainsOutperformGet Alert
05/03/2024Buy Now4.37%Barclays
Carter Gould55%
$230 → $300UpgradeUnderweight → Equal-WeightGet Alert
04/17/2024Buy Now-1.2%UBS
Colin Bristow38%
$314 → $284MaintainsNeutralGet Alert
04/17/2024Buy Now25.24%TD Cowen
Yaron Weber37%
$370 → $360MaintainsBuyGet Alert
04/12/2024Buy Now11.33%Truist Securities
Robyn Karnauskas54%
$320 → $320ReiteratesBuy → BuyGet Alert
04/09/2024Buy Now-5.72%Morgan Stanley
Terence Flynn65%
$278 → $271MaintainsEqual-WeightGet Alert
04/03/2024Buy Now14.46%RBC Capital
Gregory Renza50%
$329 → $329ReiteratesOutperform → OutperformGet Alert
03/28/2024Buy NowRaymond James
Gary Nachman59%
Reinstates → Market PerformGet Alert
02/08/2024Buy Now21.76%Goldman Sachs
Salveen Richter52%
$313 → $350MaintainsBuyGet Alert
02/07/2024Buy Now-3.28%Morgan Stanley
Terence Flynn65%
$281 → $278MaintainsEqual-WeightGet Alert
02/07/2024Buy Now14.46%RBC Capital
Gregory Renza50%
$303 → $329MaintainsOutperformGet Alert
02/07/2024Buy Now21.76%Goldman Sachs
Salveen Richter52%
$313 → $350MaintainsBuyGet Alert
02/01/2024Buy Now21.76%Oppenheimer
Jay Olson60%
→ $350ReiteratesOutperform → OutperformGet Alert
01/29/2024Buy Now9.24%UBS
Colin Bristow38%
$315 → $314MaintainsNeutralGet Alert
12/21/2023Buy Now11.33%Daiwa Capital
Narumi Nakagiri23%
→ $320UpgradeNeutral → BuyGet Alert
12/19/2023Buy Now13.41%BMO Capital
Evan David Seigerman46%
$286 → $326UpgradeMarket Perform → OutperformGet Alert
12/12/2023Buy Now4.37%RBC Capital
Gregory Renza50%
$256 → $300UpgradeSector Perform → OutperformGet Alert
11/29/2023Buy Now11.33%Truist Securities
Robyn Karnauskas54%
→ $320ReiteratesBuy → BuyGet Alert
11/09/2023Buy Now-16.5%Deutsche Bank
James Shin45%
→ $240Initiates → HoldGet Alert
11/02/2023Buy Now-10.94%RBC Capital
Gregory Renza50%
$253 → $256MaintainsSector PerformGet Alert
11/02/2023Buy Now11.33%Truist Securities
Robyn Karnauskas54%
→ $320UpgradeHold → BuyGet Alert
11/02/2023Buy Now-6.76%UBS
Colin Bristow38%
$272 → $268MaintainsNeutralGet Alert
11/01/2023Buy Now-10.94%RBC Capital
Gregory Renza50%
$253 → $256MaintainsSector PerformGet Alert
11/01/2023Buy Now1.24%Morgan Stanley
Terence Flynn65%
$300 → $291MaintainsEqual-WeightGet Alert
10/25/2023Buy Now7.85%Oppenheimer
Jay Olson60%
$300 → $310MaintainsOutperformGet Alert
10/20/2023Buy Now4.37%Oppenheimer
Jay Olson60%
$290 → $300MaintainsOutperformGet Alert
10/20/2023Buy Now-6.07%JP Morgan
Chris Schott59%
→ $270ReinstatesNeutral → NeutralGet Alert
10/17/2023Buy Now7.85%Argus Research
David Toung69%
$280 → $310MaintainsBuyGet Alert
10/17/2023Buy Now4.37%Morgan Stanley
Terence Flynn65%
→ $300Reinstates → Equal-WeightGet Alert
10/12/2023Buy Now7.85%Jefferies
Michael Yee56%
$310 → $310ReiteratesBuy → BuyGet Alert
10/11/2023Buy Now10.63%Leerink Partners
David Risinger72%
$267 → $318UpgradeMarket Perform → OutperformGet Alert
10/11/2023Buy Now0.89%B of A Securities
Geoff Meacham62%
→ $290Reinstates → NeutralGet Alert
10/09/2023Buy Now0.89%Oppenheimer
Jay Olson60%
$280 → $290MaintainsOutperformGet Alert
09/18/2023Buy Now-2.59%Argus Research
David Toung69%
$260 → $280MaintainsBuyGet Alert
09/06/2023Buy Now11.33%HSBC
Morten Herholdt30%
→ $320Initiates → BuyGet Alert
09/05/2023Buy Now-9.55%Truist Securities
Robyn Karnauskas54%
→ $260ReiteratesHold → HoldGet Alert
08/14/2023Buy Now7.85%Jefferies
Michael Yee56%
$275 → $310MaintainsBuyGet Alert
08/14/2023Buy Now-22.42%Mizuho
Salim Syed44%
$214 → $223MaintainsNeutralGet Alert
08/04/2023Buy Now-11.98%RBC Capital
Gregory Renza50%
$250 → $253MaintainsSector PerformGet Alert
07/25/2023Buy Now-2.59%Oppenheimer
Jay Olson60%
→ $280ReiteratesOutperform → OutperformGet Alert
07/12/2023Buy Now-30.42%Credit Suisse
Trung Huynh67%
$220 → $200MaintainsOutperformGet Alert
07/11/2023Buy Now-26.94%Barclays
Carter Gould55%
$225 → $210MaintainsUnderweightGet Alert
06/26/2023Buy Now-9.55%Argus Research
David Toung69%
$270 → $260MaintainsBuyGet Alert
05/18/2023Buy Now-2.59%Oppenheimer
Jay Olson60%
→ $280ReiteratesOutperform → OutperformGet Alert
05/09/2023Buy Now-11.63%RBC Capital
Gregory Renza50%
→ $254Reiterates → Sector PerformGet Alert
05/01/2023Buy Now-21.72%Barclays
Carter Gould55%
$227 → $225MaintainsUnderweightGet Alert
04/28/2023Buy Now0.19%Piper Sandler
Christopher Raymond55%
$293 → $288MaintainsOverweightGet Alert
04/24/2023Buy Now0.89%Oppenheimer
Jay Olson60%
$292 → $290MaintainsOutperformGet Alert
04/14/2023Buy Now-21.03%Barclays
Carter Gould55%
$230 → $227MaintainsUnderweightGet Alert
03/13/2023Buy Now-7.81%Wells Fargo
Mohit Bansal66%
$275 → $265UpgradeEqual-Weight → OverweightGet Alert
02/13/2023Buy Now-9.55%Truist Securities
Robyn Karnauskas54%
$280 → $260MaintainsHoldGet Alert
02/02/2023Buy Now-7.11%SVB Leerink
David Risinger72%
$282 → $267MaintainsMarket PerformGet Alert
02/01/2023Buy Now-4.33%Wells Fargo
Mohit Bansal66%
$285 → $275MaintainsEqual-WeightGet Alert
02/01/2023Buy Now-10.24%RBC Capital
Gregory Renza50%
$268 → $258MaintainsSector PerformGet Alert

FAQ

Q

What is the target price for Amgen (AMGN) stock?

A

The latest price target for Amgen (NASDAQ:AMGN) was reported by Guggenheim on May 20, 2025. The analyst firm set a price target for $288.00 expecting AMGN to rise to within 12 months (a possible 0.19% upside). 41 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Amgen (AMGN)?

A

The latest analyst rating for Amgen (NASDAQ:AMGN) was provided by Guggenheim, and Amgen their neutral rating.

Q

When was the last upgrade for Amgen (AMGN)?

A

The last upgrade for Amgen Inc happened on May 3, 2024 when William Blair raised their price target to N/A. William Blair previously had a market perform for Amgen Inc.

Q

When was the last downgrade for Amgen (AMGN)?

A

The last downgrade for Amgen Inc happened on October 14, 2024 when Truist Securities changed their price target from $320 to $333 for Amgen Inc.

Q

When is the next analyst rating going to be posted or updated for Amgen (AMGN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amgen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amgen was filed on May 20, 2025 so you should expect the next rating to be made available sometime around May 20, 2026.

Q

Is the Analyst Rating Amgen (AMGN) correct?

A

While ratings are subjective and will change, the latest Amgen (AMGN) rating was a with a price target of $0.00 to $288.00. The current price Amgen (AMGN) is trading at is $287.44, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch